530533 TRPV4 Agonist, GSK1016790A - Calbiochem

530533
View Pricing & Availability

Overview

Replacement Information

Key Specifications Table

Empirical Formula
C₂₈H₃₂Cl₂N₄O₆S₂

Pricing & Availability

Catalog Number AvailabilityPackaging Qty/Pack Price Quantity
5.30533.0001
Retrieving availability...
Limited AvailabilityLimited Availability
Stocked 
Discontinued
Limited Quantities Available
Available
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

      Glass bottle 10 mg
      Retrieving price...
      Price could not be retrieved
      Minimum Quantity needs to be mulitiple of
      Upon Order Completion More Information
      You Saved ()
       
      Request Pricing
      Description
      OverviewA cell-permeable piperazine amide derivative that acts as a potent and selective agonist of Transient Receptor Potential Vanilloid 4 Channel (TRPV4) and enhances Ca2+ flux in a variety of human and mouse cells (EC50 = 2.1 nM and 18 nM in human and mouse TRPV4 expressed in HEK293 cells, respectively). Generates greater [Ca2+]i transients in chrondocytes than hypoosmotic treatments. Shown to be about 300-fold more potent that 4-α-PDD in activating TRPV4 channels. Suggested to act by recruiting previously inactive channels, rather than through increasing elevation of basal activity. Does not affect TRPM8 and TRPA1 channels even at high concentrations (~20 µM).

      Please note that the molecular weight for this compound is batch-specific due to variable water content.
      Catalogue Number530533
      Brand Family Calbiochem®
      SynonymsGSK101, Transient Receptor Potential Vanilloid 4 Channel Agonist
      References
      ReferencesOʹConor, C.J., 2014. PNAS. 111, 1316.
      Sullivan, M.N., et al. 2012. Mol. Pharmacol. 82, 464.
      Jun, M., et al. 2011. PLoS One. 6, e16713.
      Thorneloe, K. S., et al. 2008. J. Pharm. Exp. Ther. 326,432.
      Product Information
      FormWhite powder
      Hill FormulaC₂₈H₃₂Cl₂N₄O₆S₂
      Chemical formulaC₂₈H₃₂Cl₂N₄O₆S₂
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetTRPV4
      Purity≥98% by HPLC
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Shipped at Ambient Temperature or with Blue Ice or with Dry Ice
      Toxicity Standard Handling
      Storage -20°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications

      Documentation

      TRPV4 Agonist, GSK1016790A - Calbiochem SDS

      Title

      Safety Data Sheet (SDS) 

      References

      Reference overview
      OʹConor, C.J., 2014. PNAS. 111, 1316.
      Sullivan, M.N., et al. 2012. Mol. Pharmacol. 82, 464.
      Jun, M., et al. 2011. PLoS One. 6, e16713.
      Thorneloe, K. S., et al. 2008. J. Pharm. Exp. Ther. 326,432.
      Data Sheet

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision31-July-2014 JSW
      SynonymsGSK101, Transient Receptor Potential Vanilloid 4 Channel Agonist
      DescriptionA cell-permeable piperazine amide derivative that acts as a potent and selective agonist of Transient Receptor Potential Vanilloid 4 Channel (TRPV4) and enhances Ca2+ flux in a variety of human and mouse cells (EC50 = 2.1 nM and 18 nM in human and mouse TRPV4 expressed in HEK293 cells, respectively). Generates greater [Ca2+]i transients in chrondocytes than hypoosmotic treatments. Shown to be about 300-fold more potent that 4-α-PDD in activating TRPV4 channels. Suggested to act by recruiting previously inactive channels, rather than through increasing elevation of basal activity. Does not affect TRPM8 and TRPA1 channels even at high concentrations (~20 µM).
      FormWhite powder
      Intert gas (Yes/No) Packaged under inert gas
      Chemical formulaC₂₈H₃₂Cl₂N₄O₆S₂
      Purity≥98% by HPLC
      SolubilityDMSO (50 mg/ml)
      Storage -20°C
      Protect from light
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesOʹConor, C.J., 2014. PNAS. 111, 1316.
      Sullivan, M.N., et al. 2012. Mol. Pharmacol. 82, 464.
      Jun, M., et al. 2011. PLoS One. 6, e16713.
      Thorneloe, K. S., et al. 2008. J. Pharm. Exp. Ther. 326,432.